(Bloomberg) -- Moderna Inc. has agreed to do a placebo-controlled trial of its new Covid vaccine that was recently approved by US regulators, Health and Human Services Secretary Robert F. Kennedy Jr.
A Moderna influenza vaccine for avian influenza, or “bird flu,” will head into a pivotal clinical trial with $176 million in funding from the U.S. federal government. The funding announced by Moderna ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results